Stock data
Arcturus Therapeutics Holdings Inc. (ARCT)
Arcturus Therapeutics Holdings Inc. (ARCT) reported revenue of US$82.03M and net income of -US$65.78M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$82.03M | — | -US$76.26M | -US$65.78M | — |
| 2024 | US$152.31M | — | -US$95.67M | -US$80.94M | — |
| 2023 | US$166.80M | — | -US$78.20M | -US$29.73M | — |
| 2022 | US$206.00M | — | US$12.18M | US$9.35M | — |
| 2021 | US$12.36M | — | -US$202.85M | -US$203.67M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$2.96M | -US$23.79M | — |
| 2026-03-31 | US$2.06M | -US$26.96M | — |
| 2025-12-31 | US$7.20M | -US$29.08M | — |
| 2025-09-30 | US$17.15M | -US$13.45M | — |
| 2025-06-30 | US$28.30M | -US$9.18M | — |
| 2025-03-31 | US$29.38M | -US$14.08M | — |
| 2024-12-31 | US$22.77M | -US$30.00M | — |
| 2024-09-30 | US$41.67M | -US$6.90M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.